dc.contributor.author | Hoeper, Marius M. | |
dc.contributor.author | Gruenig, Ekkehard | |
dc.contributor.author | Jansa, Pavel | |
dc.contributor.author | Fritsch, Arno | |
dc.contributor.author | Wang, Chen | |
dc.contributor.author | Torbicki, Adam | |
dc.contributor.author | Simonneau, Gerald | |
dc.contributor.author | Neurohr, Claus | |
dc.contributor.author | Mayer, Eckhard | |
dc.contributor.author | Davie, Neil | |
dc.contributor.author | Ghofrani, Hossein-Ardeschir | |
dc.contributor.author | Kim, Nick H. | |
dc.contributor.author | D'Armini, Andrea M. | |
dc.contributor.author | Grimminger, Friedrich | |
dc.date.accessioned | 2022-02-18T10:26:06Z | |
dc.date.available | 2022-02-18T10:26:06Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Kim N. H. , D'Armini A. M. , Grimminger F., Gruenig E., Hoeper M. M. , Jansa P., Mayer E., Neurohr C., Simonneau G., Torbicki A., et al., "Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension", HEART, cilt.103, sa.8, ss.599-606, 2017 | |
dc.identifier.issn | 1355-6037 | |
dc.identifier.other | av_9b6b69be-7e2d-4e3e-8834-9131095b4d9a | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/179225 | |
dc.identifier.uri | https://doi.org/10.1136/heartjnl-2016-309621 | |
dc.description.abstract | Objective We compared the haemodynamic effects of riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy in the Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate CyclaseStimulator Trial 1 study. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | CARDIAC ve CARDIOVASCULAR SİSTEMLER | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Kardiyoloji | |
dc.subject | Cardiology and Cardiovascular Medicine | |
dc.subject | Health Sciences | |
dc.title | Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension | |
dc.type | Makale | |
dc.relation.journal | HEART | |
dc.contributor.department | UGMLC , , | |
dc.identifier.volume | 103 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 599 | |
dc.identifier.endpage | 606 | |
dc.contributor.firstauthorID | 3385377 | |